EX-99.1 2 y72397exv99w1.htm EX-99.1: PRESS RELEASE EX-99.1
Exhibit 99.1
     
PRESS RELEASE   (AMDOCS LOGO)
Amdocs Limited Reports Quarterly Revenue Growth of 14%
Amdocs Reports Record Annual Revenue of $3.16 Billion
Key highlights:
    Fourth quarter revenue increased to $825 million, in line with guidance
 
    Fourth quarter non-GAAP operating income of $148 million, an increase of 16% over prior year fourth quarter
 
    Fourth quarter diluted non-GAAP EPS, excluding acquisition-related costs, restructuring charges and equity-based compensation expense, net of related tax effects, of $0.54; foreign exchange rate losses reflected in interest expense reduced EPS by $0.08 per share
 
    Diluted GAAP EPS of $0.38 for the quarter
 
    Strong free cash flow of $145 million for the quarter, comprised of cash flow from operations of $178 million less $33 million in net capital expenditures and other
St. Louis, MO – November 5, 2008 – Amdocs Limited (NYSE: DOX) today reported that for its fiscal fourth quarter ended September 30, 2008, revenue was $825.3 million, an increase of 13.6% from last year’s fourth quarter. Net income on a non-GAAP basis was $117.2 million, or $0.54 per diluted share, compared to non-GAAP net income of $120.7 million, or $0.54 per diluted share, in the fourth quarter of fiscal 2007. Non-GAAP net income excludes amortization of purchased intangible assets, equity-based compensation expenses and restructuring changes of $34.5 million, net of related tax effects, of in the fourth quarter of fiscal 2008 and excludes such amortization and compensation expenses of $24.5 million, net of related tax effects, in the fourth quarter of fiscal 2007. The Company’s GAAP net income for the fourth quarter of fiscal 2008 was $82.7 million, or $0.38 per diluted share, compared to GAAP net income of $96.2 million, or $0.43 per diluted share, in the prior year’s fourth quarter.

 


 

“Fiscal 2008 was a good year for Amdocs as we achieved record revenues,” said Dov Baharav, chief executive officer of Amdocs Management Limited. “Revenue in the fourth quarter was up 13.6% and non-GAAP operating income rose to $148 million, an increase of 16.4% compared to the prior year fourth quarter. Our earnings per share were adversely impacted by the unprecedented extreme volatility in exchange rates, including the rapid strengthening of the U.S. dollar against offer currencies, which adversely affected certain balance sheet items denominated in other currencies, reduced fourth quarter earnings per share by $0.08. Absent this, our non-GAAP diluted earnings per share would have been within our guidance range of $0.61 to $0.63.”
In the fourth quarter Amdocs had numerous wins across lines of business and geographies. These wins include new business with Comcast, which will deploy customer care, billing and OSS (operational support systems) products based on Amdocs CES 7.5. Another customer in the cable and satellite market has chosen Amdocs Enterprise Product Catalog. Amdocs signed a six-year managed services agreement to support MetroPCS, a provider of advanced wireless services, using Amdocs CES 7.5 capabilities. In Europe, Amdocs was chosen by Debitel, the largest provider of mobile services in Germany, to provide a single billing platform to support its consolidated operations. Vodafone has selected Amdocs OSS fulfillment products for deployments in key European locations. International Telecommunications Company in the Ukraine has selected Amdocs Compact Convergence offering for real-time charging and service delivery across its CDMA network.
Baharav continued, “The financial volatility that we experienced in the fourth quarter is accompanied by economic uncertainty and these factors are impacting our outlook for fiscal 2009. Amdocs expects that revenue for the first quarter of fiscal 2009 will be approximately $785-$810 million. Foreign exchange in particular is a headwind in the first quarter of fiscal 2009, accounting for all of the decrease in forecasted revenue when compared to the fourth quarter of fiscal 2008. We are not seeing cancellations of existing projects and in fact we have signed some significant new deals in the past few weeks. Our growth engines, including emerging markets, cable and satellite and managed services, are right for this environment. However, our ability to forecast the level of new signings later in the fiscal year is impacted by these unprecedented market conditions. While we cannot today commit to guidance for the full year, we are managing our expenses under the assumption that fiscal 2009 revenue could be flat to low single-digit percentage growth for the year with operating margins similar to what

 


 

we saw in the fourth quarter. This assumes that foreign exchange rates stay relatively stable compared to mid-October levels and that economic conditions do not deteriorate materially from what we see today.”
As reported, GAAP EPS per diluted share for the fourth quarter of fiscal 2008 was $0.38. Non-GAAP EPS per diluted share was $0.54 for the quarter, (excluding acquisition-related costs which include amortization of purchased intangible assets, and excluding restructuring charges and equity-based compensation expense, net of related tax effects). The excluded pre-tax restructuring charges amounted to approximately $12 million, reducing GAAP EPS per diluted share by $0.04. The charges consist primarily of severance and other employment related obligations incurred in connection with Amdocs’ measures designed to align its operational structure to its expected future growth and to improve efficiency. During the quarter, rapid and large foreign exchange rate changes, especially the strengthening of the U.S. dollar, caused the Company to record foreign exchange rate losses of approximately $17 million net of tax, or $0.08 per diluted share. These losses were primarily due to revaluation of assets and liabilities denominated in other currencies.
For the fiscal year ended September 30, 2008, revenue increased by 11.5% to $3.16 billion. Fiscal 2008 net income on a non-GAAP basis was $499.6 million, or $2.29 per diluted share (excluding acquisition-related costs, which include amortization of purchased intangible assets and in-process research and development write-off, and excluding restructuring charges and equity-based compensation expense, net of related tax effects, of $120.7 million), compared to non-GAAP net income of $473.9 million, or $2.14 per diluted share, in fiscal 2007 (excluding acquisition-related costs, which include amortization of purchased intangible assets, in-process research and development write-off and other, and excluding restructuring charges, and equity-based compensation expense, net of related tax effects, of $108.9 million). The Company’s GAAP net income in fiscal 2008 was $378.9 million, or $1.74 per diluted share, compared to GAAP net income of $364.9 million, or $1.65 per diluted share, in fiscal 2007.

 


 

Financial Outlook
Amdocs expects that revenue for the first quarter of fiscal 2009 will be approximately $785-$810 million. Foreign exchange in particular is a headwind in the first quarter of fiscal 2009, accounting for all of the decrease in forecasted revenue when compared to the fourth quarter of fiscal 2008. Amdocs expects diluted earnings per share on a non-GAAP basis for the first quarter to be $0.54-$0.57, excluding acquisition-related costs and approximately $0.05-$0.06 per share of equity-based compensation expense, net of related tax effects. Estimated diluted GAAP EPS will not be known until after preliminary purchase price accounting adjustments for the ChangingWorlds Limited acquisition have been determined.
Amdocs will host a conference call on November 5, 2008 at 5 p.m. Eastern Time to discuss the Company’s fourth quarter results. The call will be carried live on the Internet via www.InvestorCalendar.com and the Amdocs website, www.amdocs.com.
Non-GAAP Financial Measures
This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow, non-GAAP cost of service, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP income taxes and non-GAAP net income. These non-GAAP measures exclude the following items:
    amortization of purchased intangible assets;
 
    in-process research and development write-off and other;
 
    restructuring charges;
 
    equity-based compensation expense; and
 
    tax effects related to the above.
These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs’ results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs’ results of operations in conjunction with the corresponding GAAP measures.

 


 

Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow, non-GAAP cost of service, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP income taxes and non-GAAP net income, when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business.
For its internal budgeting process and in monitoring the results of the business, Amdocs’ management uses financial statements that do not include amortization of purchased intangible assets, in-process research and development write-off and other, restructuring charges, equity-based compensation expense, and related tax effects. Amdocs’ management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these non-cash expenses in reviewing its results and those of its competitors, because the amounts of the expenses between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the expenses.
Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of service, research and development, selling, general and administrative, operating income, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments.
Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below.
About Amdocs
Amdocs is the market leader in customer experience systems innovation, enabling world-leading service providers to deliver an integrated, innovative and the intentional customer

 


 

experienceTM – at every point of service.  Amdocs provides solutions that deliver customer experience excellence, combining the software, service and expertise to help its customers execute their strategies and achieve service, operational and financial excellence. A global company with revenue of $3.16 billion in fiscal 2008, Amdocs has more than 17,000 employees and serves customers in more than 50 countries around the world. For more information, visit Amdocs at www.amdocs.com.
This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs growth and business results in future quarters. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general economic conditions, Amdocs ability to grow in the business markets that it serves, Amdocs ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company’s products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, the Company specifically disclaims any obligation to do so. These and other risks are discussed at greater length in the Company’s filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2007 filed on December 3, 2007 and on Form 6-K furnished on February 11, May 6 and August 11, 2008.
Contact:
Thomas G. O’Brien
Treasurer and Vice President of Investor Relations
Amdocs Limited
314-212-8328
E-mail: dox_info@amdocs.com

 


 

AMDOCS LIMITED
Consolidated Statements of Income
(in thousands, except per share data)
                                 
    Three months ended     Twelve months ended  
    September 30,     September 30,  
    2008     2007     2008     2007  
Revenue:
                               
License
  $ 41,917     $ 46,266     $ 135,487     $ 159,357  
Service
    783,360       680,423       3,026,609       2,676,816  
 
                       
 
    825,277       726,689       3,162,096       2,836,173  
 
                               
Operating expenses:
                               
Cost of license
    462       869       2,729       3,914  
Cost of service
    530,428       461,692       2,023,562       1,792,468  
Research and development
    57,252       55,515       225,492       230,444  
Selling, general and administrative
    103,171       95,299       404,134       370,194  
Amortization of purchased intangible assets
    20,385       19,174       86,687       74,959  
Restructuring charges, in-process research and development and other (1)
    12,116             13,896       6,761  
 
                       
 
    723,814       632,549       2,756,500       2,478,740  
 
                       
Operating income
    101,463       94,140       405,596       357,433  
 
                               
Interest (expense) income and other, net
    (11,842 )     13,638       11,955       50,566  
 
                       
Income before income taxes
    89,621       107,778       417,551       407,999  
 
                               
Income taxes
    6,910       11,535       38,645       43,062  
 
                       
Net income
  $ 82,711     $ 96,243     $ 378,906     $ 364,937  
 
                       
Basic earnings per share
  $ 0.40     $ 0.46     $ 1.83     $ 1.76  
 
                       
Diluted earnings per share (2)
  $ 0.38     $ 0.43     $ 1.74     $ 1.65  
 
                       
Basic weighted average number of shares outstanding
    205,164       209,371       206,590       207,846  
 
                       
Diluted weighted average number of shares outstanding
    217,479       224,033       219,606       223,256  
 
                       
 
(1)   Restructuring charges, in-process research and development and other for the twelve months ended September 30, 2008 include restructuring charges of $12,116 and in-process research and development of $1,780.
 
(2)   To reflect the impact of assumed conversion of the convertible notes, $985 and $3,940, representing interest expense and amortization of issuance costs, were added back to net income for the three and twelve months ended September 30, 2008 and 2007, respectively.

 


 

AMDOCS LIMITED
Selected Financial Metrics
(in thousands, except per share data)
                                 
    Three months ended   Twelve months ended
    September 30,   September 30,
    2008   2007   2008   2007
Revenue
  $ 825,277     $ 726,689     $ 3,162,096     $ 2,836,173  
 
                               
Non-GAAP operating income
    147,744       126,931       563,669       492,740  
 
                               
Non-GAAP net income
    117,208       120,708       499,608       473,871  
 
                               
Non-GAAP diluted earnings per share (1)
  $ 0.54     $ 0.54     $ 2.29     $ 2.14  
 
                               
Diluted weighted average number of shares outstanding
    217,479       224,033       219,606       223,256  
 
(1)   To reflect the impact of assumed conversion of the convertible notes, $985 and $3,940, representing interest expense and amortization of issuance costs, were added back to net income for the three and twelve months ended September 30, 2008 and 2007, respectively.

 


 

AMDOCS LIMITED
Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP
(in thousands)
                                                 
    Three months ended
  September 30, 2008
            Reconciliation items    
            Amortization                    
            of purchased           Equity based        
            intangible   Restructuring   compensation        
    GAAP   assets   charges   expense   Tax effect   Non-GAAP
   
Operating expenses:
                                               
Cost of license
  $ 462     $     $     $     $     $ 462  
Cost of service
    530,428                   (5,836 )           524,592  
Research and development
    57,252                   (1,088 )           56,164  
Selling, general and administrative
    103,171                   (6,856 )           96,315  
Amortization of purchased intangible assets
    20,385       (20,385 )                        
Restructuring charges, in-process research and development and other
    12,116             (12,116 )                  
   
Total operating expenses
    723,814       (20,385 )     (12,116 )     (13,780 )         $ 677,533  
   
 
                                               
   
Operating income
    101,463       20,385       12,116       13,780             147,744  
   
 
                                               
   
Income taxes
    6,910                         11,784       18,694  
   
 
                                               
   
Net income
  $ 82,711     $ 20,385     $ 12,116     $ 13,780     $ (11,784 )   $ 117,208  
   
                                         
    Three months ended
    September 30, 2007
            Reconciliation items    
            Amortization        
            of purchased   Equity based            
            intangible   compensation        
    GAAP   assets   expense   Tax effect   Non-GAAP
     
Operating expenses:
                                       
Cost of license
  $ 869     $     $     $     $ 869  
Cost of service
    461,692             (6,504 )           455,188  
Research and development
    55,515             (1,475 )           54,040  
Selling, general and administrative
    95,299             (5,638 )           89,661  
Amortization of purchased intangible assets
    19,174       (19,174 )                  
     
Total operating expenses
    632,549       (19,174 )     (13,617 )           599,758  
     
 
                                       
     
Operating income
    94,140       19,174       13,617             126,931  
     
 
                                       
     
Income taxes
    11,535                   8,326       19,861  
     
 
                                       
     
Net income
  $ 96,243     $ 19,174     $ 13,617     $ (8,326 )   $ 120,708  
     

 


 

AMDOCS LIMITED
Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP
(in thousands)
                                                 
    Twelve months ended
    September 30, 2008
            Reconciliation items    
                    Restructuring            
            Amortization   charges and            
            of purchased   in-process   Equity based        
            intangible   research and   compensation        
    GAAP   assets   development   expense   Tax effect   Non-GAAP
     
Operating expenses:
                                               
Cost of license
  $ 2,729     $     $     $     $     $ 2,729  
Cost of service
    2,023,562                   (23,547 )           2,000,015  
Research and development
    225,492                   (4,714 )           220,778  
Selling, general and administrative
    404,134                   (29,229 )           374,905  
Amortization of purchased intangible assets
    86,687       (86,687 )                        
Restructuring charges, in-process research and development and other
    13,896             (13,896 )                  
     
Total operating expenses
    2,756,500       (86,687 )     (13,896 )     (57,490 )           2,598,427  
     
 
                                               
     
Operating income
    405,596       86,687       13,896       57,490             563,669  
     
 
                                               
     
Income taxes
    38,645                         37,371       76,016  
     
 
                                               
     
Net income
  $ 378,906     $ 86,687     $ 13,896     $ 57,490     $ (37,371 )   $ 499,608  
     
                                                 
    Twelve months ended
    September 30, 2007
            Reconciliation items    
                    Restructuring            
                    charges,            
            Amortization   in-process            
            of purchased   research and   Equity based        
            intangible   development   compensation        
    GAAP   assets   and other   expense   Tax effect   Non-GAAP
     
Operating expenses:
                                               
Cost of license
  $ 3,914     $     $     $     $     $ 3,914  
Cost of service
    1,792,468                   (25,418 )           1,767,050  
Research and development
    230,444                   (6,574 )           223,870  
Selling, general and administrative
    370,194                   (21,595 )           348,599  
Amortization of purchased intangible assets
    74,959       (74,959 )                        
Restructuring charges, in-process research and development and other
    6,761             (6,761 )                  
     
Total operating expenses
    2,478,740       (74,959 )     (6,761 )     (53,587 )           2,343,433  
     
 
                                               
     
Operating income
    357,433       74,959       6,761       53,587             492,740  
     
 
                                               
     
Income taxes
    43,062                         26,373       69,435  
     
 
                                               
     
Net income
  $ 364,937     $ 74,959     $ 6,761     $ 53,587     $ (26,373 )   $ 473,871  
     

 


 

AMDOCS LIMITED
Condensed Consolidated Balance Sheets
(in thousands)
                 
    As of
    September 30,     September 30,  
    2008     2007  
ASSETS
               
Current assets
               
Cash, cash equivalents and short-term interest-bearing investments
  $ 1,244,378     $ 1,179,280  
Accounts receivable, net, including unbilled of $48,264 and $43,870 respectively (*)
    573,764       473,847  
Deferred income taxes and taxes receivable
    84,515       117,623  
Prepaid expenses and other current assets
    102,930       98,746  
 
           
Total current assets
    2,005,587       1,869,496  
 
               
Equipment, vehicles and leasehold improvements, net
    317,081       283,839  
Goodwill and other intangible assets, net
    1,796,922       1,792,588  
Other noncurrent assets (*)
    459,473       399,427  
 
           
Total assets
  $ 4,579,063     $ 4,345,350  
 
           
 
               
LIABILITIES AND SHAREHOLDERS’ EQUITY
               
 
               
Current Liabilities
               
Accounts payable and accruals
  $ 600,285     $ 592,937  
Short-term portion of capital lease obligations and other financing arrangements
    1,660       2,055  
Deferred revenue (*)
    197,851       174,526  
Deferred income taxes and taxes payable
    30,228       205,960  
 
           
Total current liabilities
    830,024       975,478  
0.50% Convertible notes
    450,000       450,000  
Noncurrent liabilities and other
    493,848       319,629  
Shareholders’ equity
    2,805,191       2,600,243  
 
           
Total liabilities and shareholders’ equity
  $ 4,579,063     $ 4,345,350  
 
           
 
(*)   Certain amounts in prior period financial statements have been reclassified to conform to the current period presentation.
# # #